HIV viral load (VL) monitoring is a central tool to evaluate ART effectiveness and transmission risk. There is a global movement to expand VL monitoring following recent recommendations from the World Health Organization (WHO), but there has been little research into VL monitoring in pregnant women. We investigated one important question in this area: when and how frequently VL should be monitored in women initiating ART during pregnancy to predict VL at the time of delivery in a simulated South African population.

中文翻译：

---

怀孕期间监测病毒载量的最佳时机，以预测南非开始抗逆转录病毒疗法的 HIV 感染妇女分娩时的病毒血症：一项模拟研究

HIV 病毒载量 (VL) 监测是评估 ART 有效性和传播风险的核心工具。根据世界卫生组织 (WHO) 最近的建议，全球范围内扩大了 VL 监测，但对孕妇 VL 监测的研究很少。我们研究了该领域的一个重要问题：在模拟南非人群中，应在怀孕期间开始 ART 的女性中监测 VL 的时间和频率，以预测分娩时的 VL。